As of 2025-09-18, the EV/EBITDA ratio of NGM Biopharmaceuticals Inc (NGM) is -0.49. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. NGM's latest enterprise value is 72.71 mil USD. NGM's TTM EBITDA according to its financial statements is -149.48 mil USD. Dividing these 2 quantities gives us the above NGM EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.6x - 7.1x | 5.2x |
| Forward P/E multiples | 6.2x - 8.1x | 6.8x |
| Fair Price | (10.44) - (12.05) | (10.12) |
| Upside | -777.7% - -882.3% | -757.3% |
| Date | EV/EBITDA |